"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
When appropriate, patients should be informed in advance that they may experience temporary loss of sensation and motor activity, usually in the lower half of the body, following proper administration of epidural anesthesia.
Last reviewed on RxList: 1/10/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Xylocaine Information
Report Problems to the Food and Drug Administration
Find out what women really need.